Express Scripts

• 

  Specialty drug prices to surge

  By Kathryn Mayer  |  May 21, 2013

  U.S. spending on specialty prescription drugs is likely to increase 67 percent by the end of 2015, according to data from Express Scripts.

• Analyst lifts Express Scripts rating, price target

  By The Associated Press  |  May 13, 2013

  A Jefferies analyst lifted his rating and price target for Express Scripts on Monday, saying uncertainties surrounding member enrollment and contract attrition is gone.

• 

  Medication waste came to $418 billion in '12

  By Kathryn Mayer  |  April 23, 2013

  Talk about a dose of bad medicine: The United States wasted $418 billion in 2012 based on bad medication-related decisions, and the impact was most deeply felt in those states that could least afford it.

• Americans express confidence in upcoming exchanges

  By Kathryn Mayer  |  March 19, 2013

  Though the health care market is seemingly hard to navigate—especially as health reform, including its exchanges, is changing the industry—Americans say they aren’t too worried about their ability to navigate the system.

• Express Scripts boasts huge fourth quarter

  By The Associated Press  |  February 19, 2013

  Mail-order and online druggist Express Scripts said on Monday its earnings jumped almost 74 percent as more people used generic drugs and it continued to absorb Medco Health Solutions.

• Branded drug costs outpacing inflation

  By Amanda McGrory-Dixon  |  November 30, 2012

  The costs of branded pharmaceutical drugs is far outpacing the economic inflation rate of 2 percent as prices jumped 13.3 percent from September 2011 to September 2012.

• 

  Watching out for auto-refills on prescription drugs

  By Dave Marley  |  November 19, 2012

  Complex language and fee structures make pharmacy benefit managers tricky to deal with—and the results can often be hazardous to an employers’ bottom line.

• Express Scripts gets upgrade

  By The Associated Press  |  November 15, 2012

  The severe decline for shares of Express Scripts this month is a buying opportunity, according to Citi, which upgraded the company.

• Express Scripts profits climb

  By The Associated Press  |  November 5, 2012

  Express Scripts reported a 20 percent boost in profit for the third quarter, but executives for the pharmacy benefit manager cautioned that the company faces a weaker outlook heading into 2013, and its shares plunged in aftermarket trading.

• Analyst: Walgreen poised for growth, rates 'Buy'

  By The Associated Press  |  September 25, 2012

  A Goldman Sachs analyst on Tuesday issued a "Buy" rating for Walgreen Co., saying that he expects its profit growth to pick up as the drug store operator recaptures lost Express Scripts business and gets a boost from its investment in a Europe-based drugstore chain.